Deans and professors from research institutions visited our company for guidance
Release time:
2020-10-28 11:27
On the morning of October 27th, the deans and professors of Tai'an University, Hebei University of Science and Technology, and Chemical Research Institute, as well as park leaders, visited our company for guidance. The chairman warmly received the manager of the quality management department and the vice president of production. During the visit, a detailed explanation was given on the current business situation and future development plans of the company. After the meeting, we visited the QC laboratory and the Quality Control Manager introduced the laboratory configuration and equipment to everyone. Experts and professors also analyzed and explained the international market situation, the current situation and future development trends of the pharmaceutical industry.
In the future, our company will continue to maintain close cooperation with experts and professors from various universities and research institutes, continuously optimize and innovate, and manufacture high-quality amino acid raw materials.
Related News
Premium L-Lysine HCL: Uses, Quality Standards & Sourcing 2026 Guide
This 2026 comprehensive guide breaks down core properties, grade classification, industrial applications, quality testing protocols and B2B sourcing tips for L-Lysine HCL, combining Jirong Pharmaceutical’s 22-year production experience of GMP-certified amino acid products to help global buyers select qualified, cost-effective raw materials that meet USP, EP and FDA regulatory standards.
Premium L-Lysine HCL: High Purity Pharmaceutical Grade Amino Acid
This 2026 E-E-A-T compliant guide for L-Lysine HCL covers its core definition, key industrial use cases, quality testing protocols, sourcing best practices and common industry questions. Backed by Jirong Pharmaceutical's 18 years of amino acid manufacturing experience, it provides authoritative, practical data to help formulators, bulk buyers and R&D teams make evidence-based procurement and product development decisions.
L-Lysine HCL: Premium Pharma Grade Amino Acid from Jirong Pharmaceutical
This comprehensive guide outlines core definitions, verified specifications, cross-industry applications, quality testing protocols, safety guidelines and 2026 market insights for L-Lysine HCL, leveraging Jirong Pharmaceutical’s on-site production experience to help global buyers make compliant, cost-effective procurement decisions aligned with latest regulatory requirements.
Premium Pharmaceutical Grade L-Lysine HCL 2026 | Jirong Pharmaceutical Complete Guide
This 2026 updated guide systematically introduces core attributes, production standards, application scenarios, purchasing tips and frequently asked questions of L-Lysine HCL. Backed by Jirong Pharmaceutical’s 14 years of amino acid manufacturing experience, it offers authoritative data to help B2B buyers select qualified high-quality L-Lysine HCL products easily.
L-Lysine HCL: 2026 Complete Guide to Pharma Grade Uses & Sourcing
This 2026 practical guide for L-Lysine HCL is developed based on Jirong Pharmaceutical’s 22 years of amino acid manufacturing experience, covering official definitions, application scenarios, quality testing criteria, common quality pitfalls and procurement tips, to help global pharma, nutrition and feed buyers source compliant, high-purity L-Lysine HCL products efficiently.
2026 Ultimate Guide to Pharmaceutical Grade Amino Acid: Benefits & Sourcing
This 2026 E-E-A-T compliant guide from Jirong Pharmaceutical covers core definitions, grading standards, evidence-backed benefits, common applications, and sourcing best practices for amino acid products. It integrates 2026 peer-reviewed research, 18+ years of production experience, and direct answers to top public queries, helping pharma manufacturers, supplement producers and end users make compliant, informed decisions.
Shijiazhuang Jirong Pharmaceutical Co., Ltd.
Address: No.8 North of Huagong Road, Circular Chemical Industry Zone, Shijiazhuang, Hebei, China
Sales line:86-0311-85157950
